Table 2.
Outcomes by patient including splenic size changes, radiation-related cytopenias, and survival
| ID | Age | Sex | Spleen size change during radiation | Spleen size change in first year post-HCT | Radiation-related platelet change (/µL) | Radiation-related leukocyte change (/µL) | Radiation-related hemoglobin reduction (g/dL) | Total body irradiation | Engraftment | Survival | Survival length (years) | Neutrophil engraftment (days) | Platelet engraftment (days) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 71 | M | -8.3% | N/A | -8000 | -6200 | -0.9 | N | Y | Y | 4.3 | 16 | 112 | |||
| 2 | 54 | F | -17.6% | -14.2% | +31,000 | -1000 | +0.1 | N | Y | Y | 0.4 | 15 | 16 | |||
| 3 | 60 | M | -3.9% | N/A | -36,000 | -7000 | -0.5 | N | Y | Y | 4.9 | 18 | 30 | |||
| 4 | 74 | M | -7.3% | -23.9% | +10,000 | -2100 | +0.2 | N | Y | Y | 4.2 | 17 | 131 | |||
| 5 | 67 | F | -10.3% | -14.4% | -103,000 | -16,500 | -0.4 | N | Y | N | 0.7 | 23 | - | |||
| 6 | 57 | M | -7.3% | -6.8% | -36,000 | -1500 | -0.4 | N | Y | Y | 3.0 | 17 | 20 | |||
| 7 | 70 | M | -22.5% | N/A | -15,000 | -10,000 | -0.1 | N | Y | Y | 5.7 | 16 | 20 | |||
| 8 | 68 | M | 0% | -15.3% | -72,000 | -7800 | -0.9 | Y | Y | Y | 8.9 | 25 | 108 | |||
| 9 | 63 | M | -16.7% | -36.5% | +8000 | -11,800 | -1.8 | N | Y | N | 0.3 | 24 | - | |||
| 10 | 46 | M | 0% | N/A | -74,000 | +1600 | + 0.6 | Y | Y | Y | 4.0 | 16 | 32 | |||
| 11 | 53 | F | -5.9% | -12% | -76,000 | -1000 | -1.3 | N | Y | N | 0.6 | 24 | - | |||
| 12 | 48 | M | 0% | -2.3% | 0 | 0 | + 1 | Y | Y | Y | 0.5 | 18 | 29 | |||
| 13 | 46 | F | -6% | 0% | -19,000 | -6300 | -1.9 | N | Y | Y | 4.6 | 22 | 91 | |||
| 14 | 61 | M | -7.7% | -18.9% | -9000 | -29,000 | + 0.3 | Y | Y | Y | 1.1 | 21 | 27 | |||
| 15 | 65 | M | -15% | -16.7% | -34,000 | -6400 | + 0.2 | N | Y | Y | 4.3 | 32 | 107 | |||
| 16 | 72 | M | -5.7% | 5.3% | -108,000 | -27,900 | -1.7 | N | Y | Y | 5.7 | 17 | 26 | |||
| 17 | 66 | M | -9.6% | N/A | -3000 | -900 | + 0.9 | Y | Y | Y | 0.3 | 26 | 48 | |||
Abbreviation: F = female; HCT = hematopoietic cell transplantation; M = male; N = no; N/A = not applicable; Y = yes.